Promising PTFE-coating technology of Optimus-CVS™ stents: The new player for congenital heart disease interventions

Background: The use of covered stents (CVS) in congenital heart disease (CHD) interventions is increasing but intrinsic properties of commercially available material remain not optimal. The Optimus-CVS™ (AndraTec GmbH, Koblenz, Germany) is a new balloon-expandable, non-premounted, Cobalt–Chromium st...

Full description

Bibliographic Details
Main Authors: Raymond N. Haddad, MD, Damien Bonnet, MD, PhD, Jean-Marc Alsac, MD, PhD, Sophie Malekzadeh-Milani, MD
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:International Journal of Cardiology Congenital Heart Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666668522000064